UCL Technology Fund makes GBP1 million investment in gene therapy company Freeline Therapeutics
The UCL Technology Fund (UCLTF) is making an investment of up to GBP1 million in biopharmaceutical company, Freeline Therapeutics (Freeline). Freeline is developing and commercialising gene therapies for bleeding and other life threatening or debilitating disorders. The therapies, which are from one single treatment, have the potential to provide long-term
